Latest reported quarter: Q2, ended Jun 2026
Quarter 2026/Q2
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $1.02B | $1.06B | $3.96B | $975.22M | $928.81M |
| Total Operating Revenue | $1.02B | $1.06B | $3.96B | $975.22M | $928.81M |
| Cost of Revenue | $873.90M | $896.44M | $3.43B | $847.75M | $827.95M |
| Gross Profit | $141.91M | $163.24M | $526.56M | $127.48M | $100.87M |
| Operating Expense | $99.67M | $98.60M | $416.08M | $102.58M | $104.05M |
| Selling and Admin Expenses | $53.66M | $52.31M | $238.40M | $58.39M | $59.10M |
| -General & Admin Expense | $53.66M | $52.31M | $238.40M | $58.39M | $59.10M |
| Depreciation & Amortization & Depletion | $46.01M | $46.30M | $177.68M | $44.19M | $44.95M |
| -Depreciation & Amortization | $46.01M | $46.30M | $177.68M | $44.19M | $44.95M |
| Operating Profit | $42.24M | $64.64M | $110.49M | $24.90M | -$3.18M |
| Net Non-Operating Interest Income (Expense) | -$11.14M | -$12.41M | -$45.35M | -$12.36M | -$11.11M |
| Non-Operating Interest Expense | $11.14M | $12.41M | $45.35M | $12.36M | $11.11M |
| Other Income (Expense) | -$3.97M | -$5.53M | -$73.33M | -$38.20M | -$33.24M |
| Special Income (Charges) | -$3.97M | -$5.53M | -$73.33M | -$38.20M | -$33.24M |
| -Less:Restructuring and Mergern & Acquisition | $1.39M | – | $1.93M | $5.53M | $781,000.00 |
| -Less:Write Off | $2.58M | $5.53M | $43.20M | $4.48M | $32.46M |
| Pretax Profit | $27.12M | $46.69M | -$8.19M | -$25.65M | -$47.53M |
| Tax | -$6.67M | -$10.29M | -$26.70M | -$16.45M | -$2.40M |
| Earnings from Equity Interest Net of Tax | -$864,000.00 | -$178,000.00 | -$4.74M | -$1.31M | -$337,000.00 |
| Net Profit | $32.58M | $57.24M | $13.23M | -$11.76M | -$45.28M |
| Profit from Continuing Operations | $32.93M | $56.80M | $13.77M | -$10.51M | -$45.47M |
| Net Income from Discontinuous Operations | -$350,000.00 | $432,000.00 | -$537,000.00 | -$1.25M | $189,000.00 |
| Minority Interests | $1.24M | $1.58M | $4.99M | $1.71M | $583,000.00 |
| Net Income to Parent Company | $31.34M | $55.65M | $8.24M | -$13.48M | -$45.86M |
| Net Income to Common Stockholders | $31.34M | $55.65M | $8.24M | -$13.48M | -$45.86M |
| Basic EPS | $0.37 | $0.65 | $0.10 | -$0.16 | -$0.54 |
| Diluted EPS | $0.36 | $0.65 | $0.10 | -$0.16 | -$0.54 |
| Dividend Per Share | $0.00 | $0.00 | $0.45 | $0.00 | $0.15 |
| -Less:Impairment of Capital Assets | – | – | $28.19M | – | – |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Assets | $3.12B | $3.11B | $3.17B | $3.17B | $3.28B |
| Total Current Assets | $209.59M | $208.80M | $269.64M | $269.64M | $351.25M |
| Cash and Cash Equivalents & Short-Term Investments | $66.61M | $71.30M | $59.46M | $59.46M | $66.48M |
| -Cash and Cash Equivalents | $66.61M | $71.30M | $59.46M | $59.46M | $66.48M |
| Receivables | $42.03M | $36.79M | $102.22M | $102.22M | $175.65M |
| -Accounts Receivable | $42.03M | $36.79M | $102.22M | $102.22M | $175.65M |
| Prepaid Assets | $21.37M | $28.13M | $24.02M | $24.02M | $34.07M |
| Inventory | $60.31M | $53.20M | $61.49M | $61.49M | $59.18M |
| Current Deferred Assets | $12.92M | $13.63M | $17.16M | $17.16M | $11.29M |
| Other Current Assets | $6.35M | $5.75M | $5.30M | $5.30M | $4.59M |
| Total Non-Current Assets | $2.91B | $2.91B | $2.90B | $2.90B | $2.93B |
| Net PPE | $1.87B | $1.88B | $1.89B | $1.89B | $1.91B |
| -Gross PPE | $1.87B | $1.88B | $3.48B | $3.48B | $1.91B |
| Investments and Advances | $66.69M | $66.40M | $63.97M | $63.97M | $64.71M |
| Goodwill and Other Intangible Assets | $608.49M | $609.45M | $632.76M | $632.76M | $662.01M |
| -Goodwill | $185.14M | $185.14M | $185.14M | $185.14M | $213.32M |
| -Other Intangible Assets | $423.35M | $424.31M | $447.63M | $447.63M | $448.69M |
| Non-Current Deferred Assets | $253.01M | $242.46M | $233.17M | $233.17M | $212.67M |
| Other Non-Current Assets | $114.99M | $110.28M | $80.46M | $80.46M | $80.70M |
| Total Liabilities | $2.68B | $2.72B | $2.83B | $2.83B | $2.93B |
| Total Current Liabilities | $824.04M | $799.88M | $878.65M | $878.65M | $774.42M |
| Payables | $153.63M | $144.52M | $138.19M | $138.19M | $141.69M |
| -Accounts Payable | $153.63M | $144.52M | $138.19M | $138.19M | $141.69M |
| Current Accrued Expenses | $99.08M | $70.22M | $102.17M | $102.17M | $68.45M |
| Short-Term Debt and Capital Lease Obligation | $176.82M | $177.05M | $176.27M | $176.27M | $176.25M |
| -Current Capital Lease Obligation | $176.82M | $177.05M | $176.27M | $176.27M | $176.25M |
| Current Deferred Liabilities | $310.10M | $321.39M | $377.93M | $377.93M | $295.41M |
| Other Current Liabilities | $84.41M | $86.71M | $84.09M | $84.09M | $92.62M |
| Total Non-Current Liabilities | $1.86B | $1.92B | $1.96B | $1.96B | $2.16B |
| Long Term Debt and Capital Lease Obligation | $1.74B | $1.80B | $1.83B | $1.83B | $2.02B |
| -Long Term Debt | $702.79M | $752.61M | $787.43M | $787.43M | $962.25M |
| -Long Term Capital Lease Obligation | $1.03B | $1.04B | $1.05B | $1.05B | $1.06B |
| Non-Current Deferred Liabilities | $14.53M | $14.43M | $44.97M | $44.97M | $59.96M |
| Other Non-Current Liabilities | $108.60M | $105.72M | $35.53M | $35.53M | $36.88M |
| Total Equity | $435.07M | $398.77M | $337.17M | $337.17M | $348.01M |
| Stockholders' Equity | $431.83M | $395.53M | $333.60M | $333.60M | $344.09M |
| Capital Stock | $856,000.00 | $854,000.00 | $852,000.00 | $852,000.00 | $852,000.00 |
| -Common Stock | $856,000.00 | $854,000.00 | $852,000.00 | $852,000.00 | $852,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $1.25B | $1.24B | $1.24B | $1.24B | $1.24B |
| Retained Earnings | -$830.60M | -$861.94M | -$917.60M | -$917.60M | -$904.12M |
| Gains/Losses Not Affecting Retained Earnings | $14.74M | $13.33M | $9.11M | $9.11M | $7.68M |
| Minority Interests | $3.24M | $3.24M | $3.56M | $3.56M | $3.92M |
| Financial Assets | – | $768,000.00 | – | – | – |
| -Accumulated Depreciation | – | – | -$1.58B | -$1.58B | – |
| Non-Current Accrued Expenses | – | – | $41.79M | $41.79M | $40.95M |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Operating Cash Flow | $90.92M | $75.30M | $276.69M | $119.14M | $34.43M |
| Net cash flow from continuing operations | $91.01M | $75.41M | $275.95M | $120.78M | $34.48M |
| Net Income from Continuing Operations | $32.93M | $56.80M | $13.77M | -$10.51M | -$45.47M |
| Gain/Loss from Continuing Operations | $864,000.00 | $178,000.00 | $14.07M | $2.83M | $3.59M |
| Depreciation & Depletion & Amortization | $46.01M | $46.30M | $177.68M | $44.19M | $44.95M |
| Deferred Tax | $0.00 | $0.00 | -$38.16M | -$40.45M | $1.23M |
| Other Non-Cash Items | $8.75M | $3.33M | $22.01M | $5.53M | $4.31M |
| Change in Working Capital | $1.73M | -$46.20M | $5.48M | $79.21M | -$9.72M |
| Cash Flow from Discontinued Operating Activities | -$90,000.00 | -$110,000.00 | $748,000.00 | -$1.64M | -$58,000.00 |
| Net cash flow from investing | -$43.66M | -$25.18M | $2.11M | $52.10M | -$48.78M |
| Net Cash Flow from Continuing Investing Activities | -$43.66M | -$25.18M | $3.74M | $52.10M | -$48.78M |
| Capital Expenditure | -$44.01M | -$25.18M | -$179.92M | -$55.47M | -$40.15M |
| Net Investment Purchase and Sale | $0.00 | $0.00 | -$25.70M | -$5.93M | -$7.34M |
| Financing Cash Flow | -$51.93M | -$38.24M | -$289.09M | -$178.27M | $30.51M |
| Net Cash Flow from Continuing Financing Activities | -$51.93M | -$38.24M | -$289.03M | -$178.27M | $30.51M |
| Net Issuance Payments Of Debt | -$50.68M | -$35.72M | -$243.73M | -$175.97M | $44.31M |
| Cash Dividends Paid | $0.00 | $0.00 | -$38.27M | $0.00 | -$12.76M |
| Net Other Financing Charges | -$1.25M | -$2.52M | -$6.63M | -$2.30M | -$1.04M |
| Cash Flow from Discontinued Financing Activities | $0.00 | $0.00 | -$65,000.00 | $0.00 | $0.00 |
| Ending Cash Balance | $66.61M | $71.30M | $59.46M | $59.46M | $66.48M |
| Net Change in Cash | -$4.68M | $11.87M | -$10.28M | -$7.03M | $16.15M |
| Beginning Cash Balance | $71.30M | $59.46M | $70.06M | $66.48M | $50.31M |
| Effect of Exchange Rate Changes | -$8,000.00 | -$35,000.00 | -$313,000.00 | $12,000.00 | $20,000.00 |
| Free Cash Flow | $46.91M | $50.12M | $96.77M | $63.67M | -$5.73M |
| -Change in Inventory | – | – | $6.44M | – | – |
| -Change in Payables and Accrued Expense | – | – | -$3.03M | – | – |
| -Change in Other Current Assets | – | – | -$15.70M | – | – |
| -Change in Other Current Liabilities | – | – | $13.92M | – | – |
| -Change In Other Working Capital | – | – | $3.83M | – | – |
| Net PPE Purchase and Sale | – | – | $381,000.00 | – | – |
| Net Other Investing Changes | – | – | $208.98M | – | – |
| Net Common Stock Issuance | – | – | $0.00 | $0.00 | – |
| Proceeds from Stock Option Exercised | – | – | -$399,000.00 | $0.00 | $0.00 |
| Net Business Purchase and Sale | – | – | – | – | $0.00 |
No comments yet — be the first to weigh in on BLMN.